GOLDMAN SACHS GROUP INC - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V116. A total of 14 filers reported holding EFFECTOR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$47,921
-44.5%
630,5390.0%0.00%
Q2 2023$86,384
+82.7%
630,5390.0%0.00%
Q1 2023$47,290
-3.2%
630,5390.0%0.00%
Q4 2022$48,867
-61.8%
630,5390.0%0.00%
Q3 2022$128,000
+26.7%
630,539
+24.7%
0.00%
Q2 2022$101,000
-42.3%
505,5390.0%0.00%
Q1 2022$175,000
-60.7%
505,5390.0%0.00%
Q4 2021$445,000
-45.2%
505,539
-0.4%
0.00%
Q3 2021$812,000507,7840.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ARISTEIA CAPITAL, L.L.C. 1,493,292$161,2760.00%
MMCAP International Inc. SPC 145,941$11,0920.00%
LITTLEJOHN & CO LLC 16,666$1,2670.00%
Sea Otter Advisors LLC 25,000$1,9000.00%
WHITEBOX ADVISORS LLC 298,145$22,6590.00%
III Capital Management 41,795$4,5130.00%
Tower Research Capital LLC (TRC) 23$20.00%
Parallel Advisors, LLC 64,166$4,8770.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 56,083$4,2620.00%
View complete list of EFFECTOR THERAPEUTICS INC shareholders